Great news !! Our multicenter real-world study on bladder-preserving trimodality therapy for MIBC includes 369 patients, representing the second largest series worldwide.
Proud to have coordinated this collaborative effort across Spanish institution.
https://t.co/8WfOAujYWf
Fantàstica iniciativa del Servei d’Oncologia mèdica @CSTerrassa, amb paliativistes, urgenciolegs i professionals de la ètica, tot i que la terapèutica actual del càncer es incomprensible sense les especialitats quirurgiques i d’Oncologia radioteràpica.
Volvemos de Madrid tras un nuevo curso de @iesebschool sobre cómo mejorar la comunicación y la gestión de conflictos entre personas de diferentes generaciones.
The number of cancer survivors with functional limitations has more than doubled over the past 20 years, with the prevalence at an all-time high of 70%. Results have implications for cancer care, trial outcomes reporting, and cancer survivorship. https://t.co/AtbyX9A7nj
Proud to share ou work. It is not easy to publish for physicians in the clinic, with no funds and with minimal institutional support. So thank you all!. @xmaldona@Gemmas3108@joelmrbcn@Feltes81@imembrive@ivanh1960 https://t.co/ckvBwowVZc